$54.8B revenue (Paris) manufactures vaccines, specialty care, and oncology therapeutics across 100+ countries. Recent focus on AI-powered precision medicine partnerships with biotech startups including Owkin platform for cancer decision support.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edits, or content requests — sent directly to James.